Cargando…

Drug Repositioning for Diabetes Based on 'Omics' Data Mining

Drug repositioning has shorter developmental time, lower cost and less safety risk than traditional drug development process. The current study aims to repurpose marketed drugs and clinical candidates for new indications in diabetes treatment by mining clinical ‘omics’ data. We analyzed data from ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ming, Luo, Heng, Xi, Zhengrui, Rogaeva, Ekaterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422696/ https://www.ncbi.nlm.nih.gov/pubmed/25946000 http://dx.doi.org/10.1371/journal.pone.0126082

Ejemplares similares

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

Pathway Analysis for Drug Repositioning Based on Public Database Mining
por: Pan, Yongmei, et al.
Publicado: (2014)

HeTDR: Drug repositioning based on heterogeneous networks and text mining
por: Jin, Shuting, et al.
Publicado: (2021)

Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)

Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015)

Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses
por: Amemiya, Takayuki, et al.
Publicado: (2019)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
por: Su, Eric Wen, et al.
Publicado: (2017)

Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer
por: Ivliev, Alexander E., et al.
Publicado: (2016)

Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory
por: Mucke, Hermann A. M.
Publicado: (2017)

The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis
por: Mehrabian, Mohadeseh, et al.
Publicado: (2015)

MODEM: multi-omics data envelopment and mining in maize
por: Liu, Haijun, et al.
Publicado: (2016)

Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease
por: Ma, Pei, et al.
Publicado: (2020)

PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool
por: Chen, Yen-Wei, et al.
Publicado: (2022)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network
por: Jadamba, Erkhembayar, et al.
Publicado: (2016)

Application of multiple omics and network projection analyses to drug repositioning for pathogenic mosquito-borne viruses
por: Amemiya, Takayuki, et al.
Publicado: (2021)

Adopting Text Mining on Rehabilitation Therapy Repositioning for Stroke
por: Meng, Guilin, et al.
Publicado: (2019)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Drug repositioning based on bounded nuclear norm regularization
por: Yang, Mengyun, et al.
Publicado: (2019)

Combined epigenetic/genetic study identified an ALS age of onset modifier
por: Zhang, Ming, et al.
Publicado: (2021)

DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome
por: Luo, Heng, et al.
Publicado: (2016)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Transcriptional data: a new gateway to drug repositioning?
por: Iorio, Francesco, et al.
Publicado: (2013)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Drug Repositioning by Kernel-Based Integration of Molecular Structure, Molecular Activity, and Phenotype Data
por: Wang, Yongcui, et al.
Publicado: (2013)

Systematic Drug Repositioning Based on Clinical Side-Effects
por: Yang, Lun, et al.
Publicado: (2011)

Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013)

In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022)

Polishing the crystal ball: mining multi-omics data in dermatomyositis
por: Castillo, Rochelle L., et al.
Publicado: (2021)

Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer
por: Adikusuma, Wirawan, et al.
Publicado: (2023)

Drug repositioning: a machine-learning approach through data integration
por: Napolitano, Francesco, et al.
Publicado: (2013)

Drug repositioning for idiopathic epilepsy using gene expression signature data
por: Kumar, Pawan, et al.
Publicado: (2022)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug repositioning using drug-disease vectors based on an integrated network
por: Lee, Taekeon, et al.
Publicado: (2018)

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks
por: Qin, Shimei, et al.
Publicado: (2023)

In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
por: Chen, Hailin, et al.
Publicado: (2021)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ad25k1htiavpfpec13oad7j86b